0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Single-Domain Heavy Chain Antibody Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-8I19208
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Single Domain Heavy Chain Antibody Market Research Report 2025
BUY CHAPTERS

Global Single-Domain Heavy Chain Antibody Market Research Report 2025

Code: QYRE-Auto-8I19208
Report
March 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Single-Domain Heavy Chain Antibody Market Size

The global market for Single-Domain Heavy Chain Antibody was valued at US$ 1282 million in the year 2024 and is projected to reach a revised size of US$ 2318 million by 2031, growing at a CAGR of 8.9% during the forecast period.

Single-Domain Heavy Chain Antibody Market

Single-Domain Heavy Chain Antibody Market

A single-domain heavy chain antibody is a type of antibody consisting of only one variable domain derived from the heavy chain of a traditional antibody. Unlike conventional antibodies that are composed of both heavy and light chains, single-domain antibodies (sdAbs) are smaller and more stable. These antibodies are derived from the variable regions of heavy chain antibodies found in camelids (such as camels and alpacas) and can be used in various applications, including diagnostics, therapeutics, and research, due to their high specificity, stability, and ability to bind to targets that conventional antibodies cannot.
North American market for Single-Domain Heavy Chain Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Single-Domain Heavy Chain Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Single-Domain Heavy Chain Antibody include Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Single-Domain Heavy Chain Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-Domain Heavy Chain Antibody.
The Single-Domain Heavy Chain Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Single-Domain Heavy Chain Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-Domain Heavy Chain Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Single-Domain Heavy Chain Antibody Market Report

Report Metric Details
Report Name Single-Domain Heavy Chain Antibody Market
Accounted market size in year US$ 1282 million
Forecasted market size in 2031 US$ 2318 million
CAGR 8.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Natural Single-Domain Heavy Chain Antibody
  • Recombinant Single-Domain Heavy Chain Antibody
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, HUABIO, Jackson ImmunoResearch
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Single-Domain Heavy Chain Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Single-Domain Heavy Chain Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Single-Domain Heavy Chain Antibody Market growing?

Ans: The Single-Domain Heavy Chain Antibody Market witnessing a CAGR of 8.9% during the forecast period 2025-2031.

What is the Single-Domain Heavy Chain Antibody Market size in 2031?

Ans: The Single-Domain Heavy Chain Antibody Market size in 2031 will be US$ 2318 million.

Who are the main players in the Single-Domain Heavy Chain Antibody Market report?

Ans: The main players in the Single-Domain Heavy Chain Antibody Market are Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, Pregene, Cusabio, Biocytogen, Thermo Fisher Scientific, QVQuality, HUABIO, Jackson ImmunoResearch

What are the Application segmentation covered in the Single-Domain Heavy Chain Antibody Market report?

Ans: The Applications covered in the Single-Domain Heavy Chain Antibody Market report are Treatment, Diagnosis, Research

What are the Type segmentation covered in the Single-Domain Heavy Chain Antibody Market report?

Ans: The Types covered in the Single-Domain Heavy Chain Antibody Market report are Natural Single-Domain Heavy Chain Antibody, Recombinant Single-Domain Heavy Chain Antibody

Recommended Reports

Antibody Technology

Monoclonal & VHH

Antibody Drugs

1 Single-Domain Heavy Chain Antibody Market Overview
1.1 Product Definition
1.2 Single-Domain Heavy Chain Antibody by Type
1.2.1 Global Single-Domain Heavy Chain Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Natural Single-Domain Heavy Chain Antibody
1.2.3 Recombinant Single-Domain Heavy Chain Antibody
1.3 Single-Domain Heavy Chain Antibody by Application
1.3.1 Global Single-Domain Heavy Chain Antibody Market Value by Application (2024 VS 2031)
1.3.2 Treatment
1.3.3 Diagnosis
1.3.4 Research
1.4 Global Single-Domain Heavy Chain Antibody Market Size Estimates and Forecasts
1.4.1 Global Single-Domain Heavy Chain Antibody Revenue 2020-2031
1.4.2 Global Single-Domain Heavy Chain Antibody Sales 2020-2031
1.4.3 Global Single-Domain Heavy Chain Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Single-Domain Heavy Chain Antibody Market Competition by Manufacturers
2.1 Global Single-Domain Heavy Chain Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Single-Domain Heavy Chain Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Single-Domain Heavy Chain Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Product Type & Application
2.7 Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Date of Enter into This Industry
2.8 Global Single-Domain Heavy Chain Antibody Market Competitive Situation and Trends
2.8.1 Global Single-Domain Heavy Chain Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Single-Domain Heavy Chain Antibody Players Market Share by Revenue
2.8.3 Global Single-Domain Heavy Chain Antibody Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Single-Domain Heavy Chain Antibody Market Scenario by Region
3.1 Global Single-Domain Heavy Chain Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Single-Domain Heavy Chain Antibody Sales by Region: 2020-2031
3.2.1 Global Single-Domain Heavy Chain Antibody Sales by Region: 2020-2025
3.2.2 Global Single-Domain Heavy Chain Antibody Sales by Region: 2026-2031
3.3 Global Single-Domain Heavy Chain Antibody Revenue by Region: 2020-2031
3.3.1 Global Single-Domain Heavy Chain Antibody Revenue by Region: 2020-2025
3.3.2 Global Single-Domain Heavy Chain Antibody Revenue by Region: 2026-2031
3.4 North America Single-Domain Heavy Chain Antibody Market Facts & Figures by Country
3.4.1 North America Single-Domain Heavy Chain Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Single-Domain Heavy Chain Antibody Sales by Country (2020-2031)
3.4.3 North America Single-Domain Heavy Chain Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Single-Domain Heavy Chain Antibody Market Facts & Figures by Country
3.5.1 Europe Single-Domain Heavy Chain Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Single-Domain Heavy Chain Antibody Sales by Country (2020-2031)
3.5.3 Europe Single-Domain Heavy Chain Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Single-Domain Heavy Chain Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Single-Domain Heavy Chain Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Single-Domain Heavy Chain Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Single-Domain Heavy Chain Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Single-Domain Heavy Chain Antibody Market Facts & Figures by Country
3.7.1 Latin America Single-Domain Heavy Chain Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Single-Domain Heavy Chain Antibody Sales by Country (2020-2031)
3.7.3 Latin America Single-Domain Heavy Chain Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Single-Domain Heavy Chain Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Single-Domain Heavy Chain Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Single-Domain Heavy Chain Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Single-Domain Heavy Chain Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Single-Domain Heavy Chain Antibody Sales by Type (2020-2031)
4.1.1 Global Single-Domain Heavy Chain Antibody Sales by Type (2020-2025)
4.1.2 Global Single-Domain Heavy Chain Antibody Sales by Type (2026-2031)
4.1.3 Global Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2031)
4.2 Global Single-Domain Heavy Chain Antibody Revenue by Type (2020-2031)
4.2.1 Global Single-Domain Heavy Chain Antibody Revenue by Type (2020-2025)
4.2.2 Global Single-Domain Heavy Chain Antibody Revenue by Type (2026-2031)
4.2.3 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Single-Domain Heavy Chain Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Single-Domain Heavy Chain Antibody Sales by Application (2020-2031)
5.1.1 Global Single-Domain Heavy Chain Antibody Sales by Application (2020-2025)
5.1.2 Global Single-Domain Heavy Chain Antibody Sales by Application (2026-2031)
5.1.3 Global Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2031)
5.2 Global Single-Domain Heavy Chain Antibody Revenue by Application (2020-2031)
5.2.1 Global Single-Domain Heavy Chain Antibody Revenue by Application (2020-2025)
5.2.2 Global Single-Domain Heavy Chain Antibody Revenue by Application (2026-2031)
5.2.3 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Single-Domain Heavy Chain Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sino Biological
6.1.1 Sino Biological Company Information
6.1.2 Sino Biological Description and Business Overview
6.1.3 Sino Biological Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sino Biological Single-Domain Heavy Chain Antibody Product Portfolio
6.1.5 Sino Biological Recent Developments/Updates
6.2 GenScript
6.2.1 GenScript Company Information
6.2.2 GenScript Description and Business Overview
6.2.3 GenScript Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GenScript Single-Domain Heavy Chain Antibody Product Portfolio
6.2.5 GenScript Recent Developments/Updates
6.3 Proteintech Group
6.3.1 Proteintech Group Company Information
6.3.2 Proteintech Group Description and Business Overview
6.3.3 Proteintech Group Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Proteintech Group Single-Domain Heavy Chain Antibody Product Portfolio
6.3.5 Proteintech Group Recent Developments/Updates
6.4 Abiocenter
6.4.1 Abiocenter Company Information
6.4.2 Abiocenter Description and Business Overview
6.4.3 Abiocenter Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abiocenter Single-Domain Heavy Chain Antibody Product Portfolio
6.4.5 Abiocenter Recent Developments/Updates
6.5 MerryBio
6.5.1 MerryBio Company Information
6.5.2 MerryBio Description and Business Overview
6.5.3 MerryBio Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MerryBio Single-Domain Heavy Chain Antibody Product Portfolio
6.5.5 MerryBio Recent Developments/Updates
6.6 Pregene
6.6.1 Pregene Company Information
6.6.2 Pregene Description and Business Overview
6.6.3 Pregene Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pregene Single-Domain Heavy Chain Antibody Product Portfolio
6.6.5 Pregene Recent Developments/Updates
6.7 Cusabio
6.7.1 Cusabio Company Information
6.7.2 Cusabio Description and Business Overview
6.7.3 Cusabio Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cusabio Single-Domain Heavy Chain Antibody Product Portfolio
6.7.5 Cusabio Recent Developments/Updates
6.8 Biocytogen
6.8.1 Biocytogen Company Information
6.8.2 Biocytogen Description and Business Overview
6.8.3 Biocytogen Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biocytogen Single-Domain Heavy Chain Antibody Product Portfolio
6.8.5 Biocytogen Recent Developments/Updates
6.9 Thermo Fisher Scientific
6.9.1 Thermo Fisher Scientific Company Information
6.9.2 Thermo Fisher Scientific Description and Business Overview
6.9.3 Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Product Portfolio
6.9.5 Thermo Fisher Scientific Recent Developments/Updates
6.10 QVQuality
6.10.1 QVQuality Company Information
6.10.2 QVQuality Description and Business Overview
6.10.3 QVQuality Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 QVQuality Single-Domain Heavy Chain Antibody Product Portfolio
6.10.5 QVQuality Recent Developments/Updates
6.11 HUABIO
6.11.1 HUABIO Company Information
6.11.2 HUABIO Description and Business Overview
6.11.3 HUABIO Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 HUABIO Single-Domain Heavy Chain Antibody Product Portfolio
6.11.5 HUABIO Recent Developments/Updates
6.12 Jackson ImmunoResearch
6.12.1 Jackson ImmunoResearch Company Information
6.12.2 Jackson ImmunoResearch Description and Business Overview
6.12.3 Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Product Portfolio
6.12.5 Jackson ImmunoResearch Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Single-Domain Heavy Chain Antibody Industry Chain Analysis
7.2 Single-Domain Heavy Chain Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Single-Domain Heavy Chain Antibody Production Mode & Process Analysis
7.4 Single-Domain Heavy Chain Antibody Sales and Marketing
7.4.1 Single-Domain Heavy Chain Antibody Sales Channels
7.4.2 Single-Domain Heavy Chain Antibody Distributors
7.5 Single-Domain Heavy Chain Antibody Customer Analysis
8 Single-Domain Heavy Chain Antibody Market Dynamics
8.1 Single-Domain Heavy Chain Antibody Industry Trends
8.2 Single-Domain Heavy Chain Antibody Market Drivers
8.3 Single-Domain Heavy Chain Antibody Market Challenges
8.4 Single-Domain Heavy Chain Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Single-Domain Heavy Chain Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Single-Domain Heavy Chain Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Single-Domain Heavy Chain Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Single-Domain Heavy Chain Antibody Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Single-Domain Heavy Chain Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Single-Domain Heavy Chain Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Single-Domain Heavy Chain Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Single-Domain Heavy Chain Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Single-Domain Heavy Chain Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of Single-Domain Heavy Chain Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Single-Domain Heavy Chain Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single-Domain Heavy Chain Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Single-Domain Heavy Chain Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Single-Domain Heavy Chain Antibody Sales by Region (2020-2025) & (K Units)
 Table 18. Global Single-Domain Heavy Chain Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global Single-Domain Heavy Chain Antibody Sales by Region (2026-2031) & (K Units)
 Table 20. Global Single-Domain Heavy Chain Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global Single-Domain Heavy Chain Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global Single-Domain Heavy Chain Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America Single-Domain Heavy Chain Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Single-Domain Heavy Chain Antibody Sales by Country (2020-2025) & (K Units)
 Table 27. North America Single-Domain Heavy Chain Antibody Sales by Country (2026-2031) & (K Units)
 Table 28. North America Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Single-Domain Heavy Chain Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Single-Domain Heavy Chain Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Single-Domain Heavy Chain Antibody Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Single-Domain Heavy Chain Antibody Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Single-Domain Heavy Chain Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Single-Domain Heavy Chain Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Single-Domain Heavy Chain Antibody Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Single-Domain Heavy Chain Antibody Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Single-Domain Heavy Chain Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Single-Domain Heavy Chain Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Single-Domain Heavy Chain Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Single-Domain Heavy Chain Antibody Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Single-Domain Heavy Chain Antibody Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Single-Domain Heavy Chain Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Single-Domain Heavy Chain Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Single-Domain Heavy Chain Antibody Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Single-Domain Heavy Chain Antibody Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Single-Domain Heavy Chain Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Single-Domain Heavy Chain Antibody Sales (K Units) by Type (2020-2025)
 Table 51. Global Single-Domain Heavy Chain Antibody Sales (K Units) by Type (2026-2031)
 Table 52. Global Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global Single-Domain Heavy Chain Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global Single-Domain Heavy Chain Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Single-Domain Heavy Chain Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global Single-Domain Heavy Chain Antibody Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Single-Domain Heavy Chain Antibody Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Single-Domain Heavy Chain Antibody Sales (K Units) by Application (2020-2025)
 Table 61. Global Single-Domain Heavy Chain Antibody Sales (K Units) by Application (2026-2031)
 Table 62. Global Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global Single-Domain Heavy Chain Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global Single-Domain Heavy Chain Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Single-Domain Heavy Chain Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global Single-Domain Heavy Chain Antibody Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Single-Domain Heavy Chain Antibody Price (US$/Unit) by Application (2026-2031)
 Table 70. Sino Biological Company Information
 Table 71. Sino Biological Description and Business Overview
 Table 72. Sino Biological Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sino Biological Single-Domain Heavy Chain Antibody Product
 Table 74. Sino Biological Recent Developments/Updates
 Table 75. GenScript Company Information
 Table 76. GenScript Description and Business Overview
 Table 77. GenScript Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GenScript Single-Domain Heavy Chain Antibody Product
 Table 79. GenScript Recent Developments/Updates
 Table 80. Proteintech Group Company Information
 Table 81. Proteintech Group Description and Business Overview
 Table 82. Proteintech Group Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Proteintech Group Single-Domain Heavy Chain Antibody Product
 Table 84. Proteintech Group Recent Developments/Updates
 Table 85. Abiocenter Company Information
 Table 86. Abiocenter Description and Business Overview
 Table 87. Abiocenter Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Abiocenter Single-Domain Heavy Chain Antibody Product
 Table 89. Abiocenter Recent Developments/Updates
 Table 90. MerryBio Company Information
 Table 91. MerryBio Description and Business Overview
 Table 92. MerryBio Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. MerryBio Single-Domain Heavy Chain Antibody Product
 Table 94. MerryBio Recent Developments/Updates
 Table 95. Pregene Company Information
 Table 96. Pregene Description and Business Overview
 Table 97. Pregene Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Pregene Single-Domain Heavy Chain Antibody Product
 Table 99. Pregene Recent Developments/Updates
 Table 100. Cusabio Company Information
 Table 101. Cusabio Description and Business Overview
 Table 102. Cusabio Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Cusabio Single-Domain Heavy Chain Antibody Product
 Table 104. Cusabio Recent Developments/Updates
 Table 105. Biocytogen Company Information
 Table 106. Biocytogen Description and Business Overview
 Table 107. Biocytogen Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biocytogen Single-Domain Heavy Chain Antibody Product
 Table 109. Biocytogen Recent Developments/Updates
 Table 110. Thermo Fisher Scientific Company Information
 Table 111. Thermo Fisher Scientific Description and Business Overview
 Table 112. Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Product
 Table 114. Thermo Fisher Scientific Recent Developments/Updates
 Table 115. QVQuality Company Information
 Table 116. QVQuality Description and Business Overview
 Table 117. QVQuality Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. QVQuality Single-Domain Heavy Chain Antibody Product
 Table 119. QVQuality Recent Developments/Updates
 Table 120. HUABIO Company Information
 Table 121. HUABIO Description and Business Overview
 Table 122. HUABIO Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. HUABIO Single-Domain Heavy Chain Antibody Product
 Table 124. HUABIO Recent Developments/Updates
 Table 125. Jackson ImmunoResearch Company Information
 Table 126. Jackson ImmunoResearch Description and Business Overview
 Table 127. Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Product
 Table 129. Jackson ImmunoResearch Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Single-Domain Heavy Chain Antibody Distributors List
 Table 133. Single-Domain Heavy Chain Antibody Customers List
 Table 134. Single-Domain Heavy Chain Antibody Market Trends
 Table 135. Single-Domain Heavy Chain Antibody Market Drivers
 Table 136. Single-Domain Heavy Chain Antibody Market Challenges
 Table 137. Single-Domain Heavy Chain Antibody Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Single-Domain Heavy Chain Antibody
 Figure 2. Global Single-Domain Heavy Chain Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Single-Domain Heavy Chain Antibody Market Share by Type: 2024 & 2031
 Figure 4. Natural Single-Domain Heavy Chain Antibody Product Picture
 Figure 5. Recombinant Single-Domain Heavy Chain Antibody Product Picture
 Figure 6. Global Single-Domain Heavy Chain Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Single-Domain Heavy Chain Antibody Market Share by Application: 2024 & 2031
 Figure 8. Treatment
 Figure 9. Diagnosis
 Figure 10. Research
 Figure 11. Global Single-Domain Heavy Chain Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Single-Domain Heavy Chain Antibody Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Single-Domain Heavy Chain Antibody Sales (2020-2031) & (K Units)
 Figure 14. Global Single-Domain Heavy Chain Antibody Average Price (US$/Unit) & (2020-2031)
 Figure 15. Single-Domain Heavy Chain Antibody Report Years Considered
 Figure 16. Single-Domain Heavy Chain Antibody Sales Share by Manufacturers in 2024
 Figure 17. Global Single-Domain Heavy Chain Antibody Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Single-Domain Heavy Chain Antibody Players: Market Share by Revenue in Single-Domain Heavy Chain Antibody in 2024
 Figure 19. Single-Domain Heavy Chain Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Single-Domain Heavy Chain Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Single-Domain Heavy Chain Antibody Sales Market Share by Country (2020-2031)
 Figure 22. North America Single-Domain Heavy Chain Antibody Revenue Market Share by Country (2020-2031)
 Figure 23. United States Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Single-Domain Heavy Chain Antibody Sales Market Share by Country (2020-2031)
 Figure 26. Europe Single-Domain Heavy Chain Antibody Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Single-Domain Heavy Chain Antibody Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Single-Domain Heavy Chain Antibody Revenue Market Share by Region (2020-2031)
 Figure 34. China Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Single-Domain Heavy Chain Antibody Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Single-Domain Heavy Chain Antibody Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Single-Domain Heavy Chain Antibody Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Single-Domain Heavy Chain Antibody Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Single-Domain Heavy Chain Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Single-Domain Heavy Chain Antibody by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Single-Domain Heavy Chain Antibody by Type (2020-2031)
 Figure 54. Global Single-Domain Heavy Chain Antibody Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Single-Domain Heavy Chain Antibody by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Single-Domain Heavy Chain Antibody by Application (2020-2031)
 Figure 57. Global Single-Domain Heavy Chain Antibody Price (US$/Unit) by Application (2020-2031)
 Figure 58. Single-Domain Heavy Chain Antibody Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart